38234-21-8 Usage
Description
Fertirelin, also known as Fertirelin Acetate, is a synthetic peptide that functions as a gonadotropin-releasing hormone (GnRH) agonist. It is primarily used in the veterinary field to regulate reproductive processes in animals. Fertirelin has the ability to induce estrus in dogs and cats, as well as influence the pregnancy rate in cows.
Uses
Used in Veterinary Medicine:
Fertirelin is used as a reproductive regulator for managing estrus cycles in dogs and cats. It helps in synchronizing the estrus cycle, which can lead to better breeding outcomes and increased chances of successful pregnancies.
Fertirelin is also used as a pregnancy rate enhancer in cows. By regulating the hormonal balance, it can improve the overall reproductive efficiency and pregnancy rates in the cattle industry.
Check Digit Verification of cas no
The CAS Registry Mumber 38234-21-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,2,3 and 4 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 38234-21:
(7*3)+(6*8)+(5*2)+(4*3)+(3*4)+(2*2)+(1*1)=108
108 % 10 = 8
So 38234-21-8 is a valid CAS Registry Number.
InChI:InChI=1/C55H76N16O12/c1-4-59-53(82)44-12-8-20-71(44)54(83)38(11-7-19-60-55(56)57)66-49(78)39(21-30(2)3)65-46(75)27-62-47(76)40(22-31-13-15-34(73)16-14-31)67-52(81)43(28-72)70-50(79)41(23-32-25-61-36-10-6-5-9-35(32)36)68-51(80)42(24-33-26-58-29-63-33)69-48(77)37-17-18-45(74)64-37/h5-6,9-10,13-16,25-26,29-30,37-44,61,72-73H,4,7-8,11-12,17-24,27-28H2,1-3H3,(H,58,63)(H,59,82)(H,62,76)(H,64,74)(H,65,75)(H,66,78)(H,67,81)(H,68,80)(H,69,77)(H,70,79)(H4,56,57,60)/t37-,38-,39-,40-,41-,42-,43-,44-/m0/s1
38234-21-8Relevant articles and documents
Methods for the production of peptide derivatives
-
Page/Page column 17, (2010/11/25)
The invention relates to methods for the preparation of peptides which are a C-terminal amide derivatives by a combination of solid-phase synthesis and post assembly solution phase synthesis. The peptides which are a C-terminal amide derivatives are further converted to peptide acetates. The invention also relates to pure peptide acetates and to protected peptide precursors.